Atlas Trials

Symphogen A/S

16 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Symphogen A/S

RecordFirmDate
Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies (NCT04672434)Symphogen A/S2020-11-19
Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies (NCT04641871)Symphogen A/S2020-10-12
Sym004 Versus Futuximab or Modotuximab in Patients With mCRC (NCT03549338)Symphogen A/S2018-11-29
Sym023 (Anti-TIM-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas (NCT03489343)Symphogen A/S2018-05-24
Sym021 Monotherapy, in Combination With Sym022 or Sym023, and in Combination With Both Sym022 and Sym023 in Patients With Advanced Solid Tumor Malignancies or Lymphomas (NCT03311412)Symphogen A/S2017-11-20

Track Symphogen A/S automatically

Every clearance here is in the API, with alerts when new ones post.